Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200mg twice daily to nevirapine extended release 400mg once daily (TRANxITION)

Authors

K Arasteh
D Ward
A Plettenberg
JM Livrozet
C Orkin

Document Type

Journal Article

Publication Date

2012

Journal

HIV Medicine

Volume

13

Issue

4

Inclusive Pages

236-244

APA Citation

Arasteh, K., Ward, D., Plettenberg, A., Livrozet, J., & Orkin, C. (2012). Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200mg twice daily to nevirapine extended release 400mg once daily (TRANxITION). HIV Medicine, 13 (4). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/3077